Thomas Scientific Expands Distribution and Sales Capabilities with the Acquisition of Day Associates, Inc.

120+ year industry veteran expands presence in New England area, broadens cleanroom, safety, and industrial product portfolio

North America’s largest pure-play distributor of scientific and controlled environment products, Thomas Scientific, has completed the acquisition of Massachusetts-based cleanroom, safety, and industrial products provider Day Associates, Inc. Finalized August 2, 2023, the transaction immediately expands Thomas Scientific’s national footprint, while enhancing its ability to provide products and services to companies in advanced technology and industrial segments with controlled and industrial environments.

Thomas Scientific has made six previous acquisitions since late 2017, adding eight inventory stocking locations, numerous new product lines, and teams of subject matter experts. The experience and learnings the team has gained from these very strategic acquisitions have not only substantially improved the overall capabilities to serve our customers, but to continue to add talented individuals that align with Thomas Scientific’s strong culture and core values.

Thomas Scientific’s CEO, Stan Haas, stated, “We at Thomas Scientific are very proud to partner with an industry veteran in Billy Day and his entire team. Billy has built a business over the past 45 years founded on providing personalized service and many great product brands to meet the stringent needs of their customers. By Day Associates joining the Thomas Scientific family of companies, the customers will have access to an even broader portfolio of products and a national network of distribution centers and inventory to meet their needs now and into the future.”

The Day Associates, Inc team has been led by Billy Day, who founded Day Associates in February 1977 in Dracut, MA. Day Associates continues to grow through the hard work of a dedicated team of ten employees, most of whom have been with the company for many years.

Billy Day, founder and owner of Day Associates stated, “We at Day Associates look forward to joining the Thomas Scientific team. Together, our combined resources and energies will create a stronger full-service cleanroom supply chain that will be unmatched in service, selection and quality. We are grateful to our customers. Thank you for your business. We look forward to your continued support. During this transition and into the future, the Day Associates employees you have come to know will continue to provide you with the same great service that you have come to expect.”

The primary product categories offered by Day Associates, Inc include gloves, apparel, wipers, tacky mats, masks & veils, cleanroom bags & paper, and safety products. Day has provided cleanroom, safety, and industrial products to support diverse customer segments that produce products within critical environments.

Thomas Scientific has made five previous acquisitions since late 2017, adding eight inventory stocking locations, numerous new product lines, and teams of subject matter experts. The experience and learnings the team has gained from these very strategic acquisitions have not only substantially improved the overall capabilities to serve our customers, but to continue to add talented individuals that align with Thomas Scientific’s strong culture and core values.

“I’m thrilled to welcome Day Associate’s valued customers, suppliers, and experienced associates to the Thomas Scientific Controlled Environments (CE) team! This acquisition further enhances our capability to serve our CE customers in the Northeast – New England region and reinforces our commitment to delivering personalized local – high-touch service and supply solutions to our CE customers. Together, we are well-positioned to meet the evolving needs of the advanced technology market” – Kareem Dossa, SVP, Controlled Environments at Thomas Scientific.

For the time being, Day Associates, Inc. will continue to operate independently under the Thomas Scientific umbrella. Learn more about their solutions and culture at daysupply.com (cleanroom) https://www.daysupply.com/. Thomas Scientific online at ThomasSci.com. https://www.thomassci.com/

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”